Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weiguo Lu

Showing results (41-50 of 350) with videos related to

Pageof 35
Sort By:
Cancer Science|July 22, 2024
CircMAN1A2_009 facilitates YBX1 nuclear localization to induce GLO1 activation for cervical adenocarcinoma cell growthYongjie Huang, Xinyi Wei, Mengyan Tu, et al.
Immunity, Inflammation and Disease|May 23, 2024
Differential expression of lymphocyte subpopulations in the peripheral blood of patients with COVID-19: Implications for disease severity and prognosisXinQiang Xu, JunYuan Huang, Haiqi Zhang, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|September 27, 2023
Second curettage versus conventional chemotherapy in avoiding unnecessary chemotherapy and reducing the number of chemotherapy courses for patients with gestational trophoblastic neoplasia: A systematic review and meta-analysisPeng Zhao, Yan Yu, Minmin Du, et al.
BMC Women'S Health|June 30, 2023
Cases of Yolk sac tumor associated with gynecological malignant tumorShengchao Wang, Kelie Chen, Qin Chen, et al.
Archives of Gynecology and Obstetrics|October 1, 2010
Significance of PTPRZ1 and CIN85 expression in cervical carcinomaYaxi Ma, Feng Ye, Xing Xie, et al.
BMC Cancer|May 1, 2013
MicroRNA profile of paclitaxel-resistant serous ovarian carcinoma based on formalin-fixed paraffin-embedded samplesXiao Li, Yaer Lu, Yaxia Chen, et al.
Zhonghua Fu Chan Ke Za Zhi|July 23, 2002
[Antiangiogenesis of ginsenoside Rg3 in severe combined immunodeficient mice with human ovarian carcinoma]Zimin Pan, Dafeng Ye, Xing Xie, et al.
Physics in Medicine and Biology|September 11, 2008
Adaptive fractionation therapy: I. Basic concept and strategyWeiguo Lu, Mingli Chen, Quan Chen, et al.
Physics in Medicine and Biology|June 5, 2018
Mid-range probing-towards range-guided particle therapyMingli Chen, Yuncheng Zhong, Yiping Shao, et al.
Medical Physics|December 7, 2019
Technical Note: A feasibility study on deep learning-based radiotherapy dose calculationYixun Xing, Dan Nguyen, Weiguo Lu, et al.
Pageof 35

Showing results (41-50 of 350) with videos related to

Sort By:
Pageof 35
Cancer Science|July 22, 2024
CircMAN1A2_009 facilitates YBX1 nuclear localization to induce GLO1 activation for cervical adenocarcinoma cell growthYongjie Huang, Xinyi Wei, Mengyan Tu, et al.
Immunity, Inflammation and Disease|May 23, 2024
Differential expression of lymphocyte subpopulations in the peripheral blood of patients with COVID-19: Implications for disease severity and prognosisXinQiang Xu, JunYuan Huang, Haiqi Zhang, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|September 27, 2023
Second curettage versus conventional chemotherapy in avoiding unnecessary chemotherapy and reducing the number of chemotherapy courses for patients with gestational trophoblastic neoplasia: A systematic review and meta-analysisPeng Zhao, Yan Yu, Minmin Du, et al.
BMC Women'S Health|June 30, 2023
Cases of Yolk sac tumor associated with gynecological malignant tumorShengchao Wang, Kelie Chen, Qin Chen, et al.
Archives of Gynecology and Obstetrics|October 1, 2010
Significance of PTPRZ1 and CIN85 expression in cervical carcinomaYaxi Ma, Feng Ye, Xing Xie, et al.
BMC Cancer|May 1, 2013
MicroRNA profile of paclitaxel-resistant serous ovarian carcinoma based on formalin-fixed paraffin-embedded samplesXiao Li, Yaer Lu, Yaxia Chen, et al.
Zhonghua Fu Chan Ke Za Zhi|July 23, 2002
[Antiangiogenesis of ginsenoside Rg3 in severe combined immunodeficient mice with human ovarian carcinoma]Zimin Pan, Dafeng Ye, Xing Xie, et al.
Physics in Medicine and Biology|September 11, 2008
Adaptive fractionation therapy: I. Basic concept and strategyWeiguo Lu, Mingli Chen, Quan Chen, et al.
Physics in Medicine and Biology|June 5, 2018
Mid-range probing-towards range-guided particle therapyMingli Chen, Yuncheng Zhong, Yiping Shao, et al.
Medical Physics|December 7, 2019
Technical Note: A feasibility study on deep learning-based radiotherapy dose calculationYixun Xing, Dan Nguyen, Weiguo Lu, et al.
Pageof 35